NASDAQ / LIVE COMPANY INTELLIGENCE

Satellos Bioscience Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERMSLE
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / MSLE COVERAGE

What’s moving Satellos Bioscience Inc. now

Current reporting with the operating signal separated from the noise.

01
Satellos Bioscience Inc MSCL

Satellos Bioscience Inc MSCL

The story matters when it changes Satellos Bioscience Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Satellos Bioscience Inc.: Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable ...

Satellos Bioscience Inc.: Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable ...

The development tests whether Satellos Bioscience Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
03
Satellos Bioscience Inc.: Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Satellos Bioscience Inc.: Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

The story matters when it changes Satellos Bioscience Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Satellos Bioscience Inc. Opens the Market

Satellos Bioscience Inc. Opens the Market

The story matters when it changes Satellos Bioscience Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest MSLE filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-07-08 · Period 2026-07-08SEC ↗6-KOfficial SEC filingFiled 2026-06-29 · Period 2026-06-29SEC ↗6-KOfficial SEC filingFiled 2026-06-25 · Period 2026-06-25SEC ↗6-KOfficial SEC filingFiled 2026-06-18 · Period 2026-06-17SEC ↗6-KOfficial SEC filingFiled 2026-06-17 · Period 2026-06-17SEC ↗6-KOfficial SEC filingFiled 2026-05-27 · Period 2026-05-27SEC ↗6-KOfficial SEC filingFiled 2026-05-20 · Period 2026-05-19SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-05-15SEC ↗
EARNINGS / QUARTERLY TRACKER

Satellos Bioscience Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.